Theralase Technologies Inc (TLT):製品パイプライン分析

◆英語タイトル:Theralase Technologies Inc (TLT) - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010119
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月27日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theralase Technologies Inc (Theralase) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products such as controller, multiple probe, triple probe, single probe, multiple probe, acu-point locator, stand, hard carrying case, laser safety eyewear, laser safety eye cups, laser probe, and protective covers, among others. Its lasers products find application in treating acute and chronic pain conditions, addictions and cosmetic revitalization. The company sells its products through a network of distributors in Canada, the US and internationally. Theralase is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theralase Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Theralase Technologies Inc Company Overview 4
Theralase Technologies Inc Company Snapshot 4
Theralase Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Theralase Technologies Inc – Pipeline Analysis Overview 7
Theralase Technologies Inc – Key Facts 7
Theralase Technologies Inc – Major Products and Services 8
Theralase Technologies Inc Pipeline Products by Development Stage 9
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 11
Theralase Technologies Inc Pipeline Products Overview 13
TLC-2000 Therapeutic Medical Laser System 13
TLC-2000 Therapeutic Medical Laser System Product Overview 13
TLC-3200 Medical Laser 14
TLC-3200 Medical Laser Product Overview 14
TLC-3200 Medical Laser Clinical Trial 15
TLC-3400 Medical Laser 16
TLC-3400 Medical Laser Product Overview 16
Theralase Technologies Inc – Key Competitors 17
Theralase Technologies Inc – Key Employees 18
Theralase Technologies Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Theralase Technologies Inc, Recent Developments 20
Nov 30, 2017: Theralase Discovers Theralase Cold Laser Therapy Enhances Cancer Destruction for Standard Cancer Treatments 20
Nov 29, 2017: Theralase Increases Revenue 12% for 3Q2017 Financial Statements 22
Nov 27, 2017: Theralase Therapeutic Laser Technology Enhances Cancer Destruction 24
Aug 29, 2017: Theralase Increases Revenue 14% for 2Q2017 Financial Statements 26
Aug 01, 2017: Theralase PDT Technology Used to Treat Fourth Patient for Bladder Cancer 27
May 30, 2017: Theralase Increases Revenue 23% for 1Q 2017 Financial Statements 28
Oct 05, 2016: Theralase Provides Update on ITA Application to Health Canada for TLC-3400 Dosimetry Fibre Optic Cage 31
Oct 05, 2016: Theralase Provides Update on ITA Application to Health Canada for TLC-3200 Photo Dynamic Therapy Laser System 32
Jul 29, 2016: Theralase Files ITA Application to Health Canada for TLC-3400 Dosimetry Fibre Optic Cage 32
Jul 29, 2016: Theralase Files ITA Application to Health Canada for TLC-3200 Photo Dynamic Therapy Laser System 33
Appendix 34
Methodology 34
About GlobalData 36
Contact Us 36
Disclaimer 37

List of Tables
Theralase Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Theralase Technologies Inc Pipeline Products by Equipment Type 5
Theralase Technologies Inc Pipeline Products by Indication 6
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 6
Theralase Technologies Inc, Key Facts 7
Theralase Technologies Inc, Major Products and Services 8
Theralase Technologies Inc Number of Pipeline Products by Development Stage 9
Theralase Technologies Inc Pipeline Products Summary by Development Stage 10
Theralase Technologies Inc Ongoing Clinical Trials by Trial Status 11
Theralase Technologies Inc Ongoing Clinical Trials Summary 12
TLC-2000 Therapeutic Medical Laser System - Product Status 13
TLC-2000 Therapeutic Medical Laser System - Product Description 13
TLC-3200 Medical Laser - Product Status 14
TLC-3200 Medical Laser - Product Description 14
TLC-3200 Medical Laser - A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients with Non-muscle Invasive Bladder Cancer at High Risk of Progression who Are Refractory to Bacillus Calmette-guerin Therapy and who are Medically Unfit for/refuse Cystectomy 15
TLC-3400 Medical Laser - Product Status 16
TLC-3400 Medical Laser - Product Description 16
Theralase Technologies Inc, Key Employees 18
Theralase Technologies Inc, Subsidiaries 19
Glossary 35

★海外企業調査レポート[Theralase Technologies Inc (TLT):製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pon Holdings B.V.:企業のM&A・事業提携・投資動向
    Pon Holdings B.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pon Holdings B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Telecom Argentina S.A.:企業の戦略・SWOT・財務分析
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Textron Systems Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • Vera Bradley Inc:企業の戦略・SWOT・財務分析
    Vera Bradley Inc - Strategy, SWOT and Corporate Finance Report Summary Vera Bradley Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dare Bioscience Inc (DARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Belk Inc:企業の戦略・SWOT・財務情報
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kokuyo Camlin Ltd (KOKUYOCMLN):企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tivo Corporation:戦略・SWOT・企業財務分析
    Tivo Corporation - Strategy, SWOT and Corporate Finance Report Summary Tivo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報
    Summary C-TRI Co Ltd (C-TRI), a subsidiary of DAE HWA Pharmaceutical Co Ltd, is a pharmaceutical company that offers development of new peptide drugs. The company’s products include ethicals, over-the-counter drugs, Quasi-drugs, cosmetics, amendments, pharmaceuticals, taltirelin, desmopressin, presc …
  • Sun BioPharma Inc (SNBP):企業の財務・戦略的SWOT分析
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • United Gulf Bank (B.S.C.):企業の戦略・SWOT・財務分析
    United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report Summary United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Traverse Energy Ltd (TVL):企業の財務・戦略的SWOT分析
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …
  • Phono Solar Technology Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Phono Solar Technology Co Ltd (Phono Solar), a subsidiary of Sumec Group Corp, is a renewable energy company that manufactures and markets solar photovoltaic panels. The company offers products such as solar generator, LED lights, solar modules, glass modules, phonocube, heating and cooling …
  • BKW AG (BKW):電力:M&Aディール及び事業提携情報
    Summary BKW AG (BKW) is an energy and infrastructure company, which plans, builds and operates infrastructure to produce and supply energy. It generates electricity from varied fuel sources such as hydro, nuclear, fossil, and renewable sources primarily, wind and small hydro, besides solar and bioma …
  • Owlstone Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detect …
  • Viavi Solutions Inc:企業の戦略・SWOT・財務分析
    Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pentair Plc (PNR):電力:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆